XORTX Therapeutics Inc (NASDAQ: XRTX) — Healthcare · Share Price, Chart & Market Data
About: XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.03 (+9.39%)
XRTXXORTX Therapeutics Inc
Loading watchlist status…
Trade XRTX now
XORTX Therapeutics Inc share price
XRTX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:03 am GMT+0
XRTX price performance
12.639%
5D
59.852%
1M
6.316%
YTD
-42.83%
1Y
XRTX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:03 am GMT+0
XRTX details
XRTX Market Signals